The 2025 San Antonio Breast Cancer Symposium brought plenty of data and bold new ideas to the thousands of clinicians, ...

AT SABCS 2025, researchers presented surgical outcomes for patients who received 6 months of neoadjuvant endocrine therapy for ER-positive, HER2-negative breast cancer.

Metastatic breast cancer treatment with the combination of PCS6422 and capecitabine (NGC-Cap) may increase the cancer-killing ...

Women who receive risk-based breast cancer screening recommendations discussed those recommendations with their primary care ...

Breast cancer is the most common cancer in women around the world. It has been widely studied throughout history. In fact, research on breast cancer has helped pave the way for breakthroughs in other ...

We explore the disconnect between mycological cure and cosmetic recovery in Tinea Versicolor, focusing on managing patient ...

Sacituzumab govitecan showed lower rates of dose reductions and treatment discontinuations due to adverse effects compared to chemotherapy in TNBC patients. Common adverse effects, such as diarrhea ...

As supply chains continue to evolve, professionals in the industry are faced with the challenges and complexities of creating sustainable supply chains in their organizations. The need to gain ...